avutometinib
verastem
['vs-6766']
#asco22 phase i study of vs-6766 (raf/mek clamp) from dr. minchom showed some toxicities (rash, diarrhea, mucositis, ck elevation) but none stopped treatment for toxicity. rr 18% including durable responses in two pts with #kras g12d. small cohort but encouraging. 
Director of Thoracic Oncology & Developmental Therapeutics @LombardiCancer, Associate Professor @Georgetown University #LCSM #HereWeGo #ITYSL He/Him